Published in Arzneimittelforschung on November 01, 1972
Detection of a Cytosolic Glutamine Synthetase in Leaves of Nicotiana tabacum L. by Immunocytochemical Methods. Plant Physiol (1992) 1.21
Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem (1990) 1.13
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol (1992) 1.11
Immunohistochemical analysis of ras oncogene p21 product in human gastric carcinomas and their adjacent mucosas. Pathol Res Pract (1992) 0.97
Heteromeric assembly of the cytosolic glutamine synthetase polypeptides of Medicago truncatula: complementation of a glnA Escherichia coli mutant with a plant domain-swapped enzyme. Plant Mol Biol (1997) 0.96
Expression of the prokaryotic gene for chloramphenicol acetyl transferase in Drosophila under the control of larval serum protein 1 gene promoters. J Mol Biol (1986) 0.94
Sequence conservation around the 5' ends of the larval serum protein 1 genes of Drosophila melanogaster. J Mol Biol (1986) 0.92
1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies. J Pharmacol Exp Ther (1990) 0.89
Photodecomposition of a new 1,4-dihydropyridine: furnidipine. J Pharm Sci (1994) 0.88
Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine. J Med Chem (1995) 0.87
Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies. J Pharmacol Exp Ther (1990) 0.87
Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes. J Med Chem (1980) 0.86
New approaches for genotyping of Helicobacter pylori based on amplification of polymorphisms in intergenic DNA regions and at the insertion site of the cag pathogenicity island. Med Microbiol Immunol (2000) 0.85
[Antimicrobial and tumor-inhibiting properties of dithiourethane and studies on the mechanism of action. 16. Cytostatica]. Pharmazie (1972) 0.85
Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma. J Med Chem (1988) 0.85
Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma. J Cancer Res Clin Oncol (1995) 0.84
Hepatic kinetics of SCP-1 (N-[alpha-(1,2-benzisothiazol-3(2H)-ona-1, 1-dioxide-2-yl)-acetyl]-p-aminophenol) compared with acetaminophen in isolated rat liver. Eur J Pharm Biopharm (1998) 0.82
Platinum compounds with estrogen receptor affinity. Cancer Treat Rev (1990) 0.81
1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties. J Med Chem (1982) 0.80
Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part II--The antileukemic effect. Arch Pharm (Weinheim) (1989) 0.79
Parvovirus B19 infection during pregnancy and development of hydrops fetalis despite the evidence for pre-existing anti-B19 antibody: how reliable are serological results? Clin Diagn Virol (1994) 0.79
Effects of etofibrate on platelet function: in vitro studies in human plasma. Thromb Res (1980) 0.78
[Synthesis of 14C-anpirtoline]. Arch Pharm (Weinheim) (1988) 0.78
Dichloro-[1-(hydroxyphenyl)-2-phenylethylenediamine]platinum(II) complexes: testing on the human ovarian cancer cell lines NIH: OVCAR3 and SK OV 3. Arch Pharm (Weinheim) (1992) 0.78
A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J Cancer Res Clin Oncol (1994) 0.78
[The mode of local anesthetic action of cinchocaine homologues]. Arzneimittelforschung (1970) 0.78
Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes. J Cancer Res Clin Oncol (1991) 0.78
Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines. Cancer Res (1991) 0.77
Benzylamines: synthesis and evaluation of antimycobacterial properties. J Med Chem (1984) 0.77
Effect of corn root exudates on the degradation of atrazine and its chlorinated metabolites in soils. J Environ Qual (2005) 0.77
Synthesis and biological evaluation of 2,6-di-tert-butylphenol hydrazones as 5-lipoxygenase inhibitors. Bioorg Med Chem (1998) 0.77
Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part I--The antibacterial effect. Arch Pharm (Weinheim) (1989) 0.77
[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer. J Cancer Res Clin Oncol (1993) 0.77
Mammary tumor inhibiting [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, III: Relationship between structure and estrogenic activity of the diamine ligands, their sulfatoplatinum(II) and diiodoplatinum(II) complexes. Arch Pharm (Weinheim) (1993) 0.76
[1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloro-platinum(II): an endocrine-active platinum complex with a specific prostatic tumor-inhibiting activity. Prostate (1989) 0.76
Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1- dicarboxylato]platinum(II), a novel, highly active carboplatin derivative. J Cancer Res Clin Oncol (1998) 0.76
Computer modelling of estrogenic transcriptional activation can account for different types of dose-response curves of estrogens. J Steroid Biochem Mol Biol (1993) 0.76
N,N'-Dialkyl-1,2-bis(hydroxyphenyl)ethylenediamines and N,N-dialkyl-4,5-bis(4-hydroxyphenyl)imidazolidines: syntheses and evaluation of their mammary tumor inhibiting activity. J Med Chem (1982) 0.76
Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation. Cancer Chemother Pharmacol (1992) 0.76
Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells. Br J Pharmacol (1997) 0.76
Interaction of platelets with subendothelium in rats treated with PCA-4230, a new antithrombotic agent. Effect of PCA-4230 on experimental thrombosis. Haemostasis (1992) 0.76
[Development of new antiestrogens of the 3,3'-dihydroxy-alpha, beta-diethylstilbene-type and their evaluation on the DMBA-induced hormone dependent mammary carcinoma of the SD-rat (author's transl)]. J Cancer Res Clin Oncol (1980) 0.76
Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma. J Med Chem (1984) 0.75
Development of a parenterally administrable hydrosol preparation of the "third generation platinum complex" [(+/-)-1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II). Part 1. Preparation and studies on the stability and antitumor activity. Arch Pharm (Weinheim) (1995) 0.75
Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]dichloroplatinum(II)-compl exe s, Part I: Synthesis. Arch Pharm (Weinheim) (1989) 0.75
[Antiestrogenic N-(4-hydroxyphenyl)-n-(1,1,1,-trifluoro-2-propyl)-4- hydroxybenzamides: influence of hydrophobic groups substituted in the ortho-position of the benzamide-fragment on activity]. Arch Pharm (Weinheim) (1990) 0.75
Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancer. J Cancer Res Clin Oncol (1989) 0.75
Mammary tumor inhibiting effect of 3,3'-diacetoxy-alpha, beta-dialkylstilbenes and of related stilbene oxides. J Med Chem (1982) 0.75
[The working mechanism of local anesthetics. 8. Preparation of enantiomer N-phthalylamino carbonic acids]. Pharmazie (1976) 0.75
[Mammary-tumor-inhibiting antiestrogens of the 3,3'-dihydroxy-alpha, beta-dialkylstilbene type (author's transl)]. Arch Pharm (Weinheim) (1980) 0.75
Potential antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,2-dialkyl-1,2-bis(3'-hydroxyphenyl)ethanes. J Med Chem (1981) 0.75
[Syntheses and evaluation of the potentially oestrophilic cytostatics 2,3-epoxy-3,4-bis-(4-acetoyphenyl)-4-hexene and 2,3,4,5-bisepoxy-3,4-bis-(4-acetoxyphenyl)hexane (author's transl)]. Arch Pharm (Weinheim) (1982) 0.75
The tumor-inhibiting effect of diethylstilbestrol-3,4-oxide. J Cancer Res Clin Oncol (1981) 0.75
[Azomethines and oxazolidines from norfenefrine. Development of compounds with prolonged action and blood pressure increasing effect]. Arch Pharm (Weinheim) (1975) 0.75
Carrier mediated action of platinum complexes on estrogen receptor positive tumors. Eur J Cancer Clin Oncol (1989) 0.75
[Mechanism of action of cis-bis(glycylglycine ethyl ester)platinum(II) chloride--effect on protein biosynthesis]. Arch Pharm (Weinheim) (1983) 0.75
Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes. J Cancer Res Clin Oncol (1988) 0.75
[Studies on the mechanism of action of local anesthetics. 6. Binding of local anesthetics of complementary membranes structures]. Pharmazie (1972) 0.75
Development of selectively acting platinum complexes. Cancer Treat Rev (1984) 0.75
Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane. J Cancer Res Clin Oncol (1989) 0.75
[The antineoplastic action of o-substituted [1,2-bis(4-hydroxyphenyl)-ethylenediamine]dichloroplatinum (II) complexes and their methylethers]. Arch Pharm (Weinheim) (1988) 0.75
[Activity of cis-bis(glycylglycine ethyl ester)platinum(II) chloride-effects on nucleic acid metabolism]. Arch Pharm (Weinheim) (1983) 0.75
[Studies on the mammary tumor inhibiting effect of cis-dichlorobis(glycylglycinethylester)platinum(II) (author's transl)]. Arch Pharm (Weinheim) (1981) 0.75
Effect of estrophilic platinum complex on the mouse uterus. Virchows Arch B Cell Pathol Incl Mol Pathol (1987) 0.75
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the rat. J Cancer Res Clin Oncol (1982) 0.75
Cytotoxic ester derivatives of the mammary tumor inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane. Arch Pharm (Weinheim) (1990) 0.75
Design of metallocenic drugs. IARC Sci Publ (1986) 0.75
[The action mechanisms of local anesthetics. 9. N-aminoacyl-beta-phenylalkylamine tested for development of antidepressive agents from psychotonics]. Pharmazie (1976) 0.75
Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 1. Synthesis and estrogen receptor binding affinity of 2,2'- and 3,3'-disubstituted hexestrols. J Med Chem (1983) 0.75
[The mode of action of antimycobacterial benzylamines]. Arch Pharm (Weinheim) (1989) 0.75
[Antimycobacterial N-alkylbenzylamines: synthesis and testing of 4-aminomethyl-2-hydroxybenzoic acid and its homologs]. Arch Pharm (Weinheim) (1982) 0.75
[Intraocular lenses - aphorisms of an operating practitioner (author's transl)]. Klin Monbl Augenheilkd (1979) 0.75
[N-(4-hydroxyphenyl)-N-(1,1,1-trifluor-2-propyl)-4-hydroxyben zamide: synthesis and pharmacologic evaluation of a new antiestrogen]. Arch Pharm (Weinheim) (1988) 0.75
[Investigations of pharmacokinetics and metabolic behavior of N-L-pnenylalanyl-L-2-amino-1-phenylpropane (author's transl)]. Arzneimittelforschung (1981) 0.75
N,N'-Dialkylbis(dichlorophenyl)ethylenediamines and -imidazolidines: relationship between structure and estradiol receptor affinity. J Med Chem (1980) 0.75
[The mode of action of local anesthetics. 7. Synthesis of enantiomeric N-aminoacyl-2.6.-dimethylaniline, -benzylamine and-2-phenylethylamine]. Pharmazie (1976) 0.75
[Relations between structure and antitumor activity of cis-dichloro[bis(oligopeptide-ester)]platinum(II) complexes]. Arch Pharm (Weinheim) (1983) 0.75
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. J Cancer Res Clin Oncol (1982) 0.75
Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl) ethylenediamine]dichloroplatinum(II)-complexes, Part II: Biological properties. Arch Pharm (Weinheim) (1989) 0.75
[Antitumor activity of cis-dichloro-bis-(alpha-amino acid ester)platinum complexes]. Arch Pharm (Weinheim) (1983) 0.75
A simple method of delayed processing of tumor tissue in a soft agar clonogenic assay. J Cancer Res Clin Oncol (1988) 0.75
[Synthesis and tumor inhibiting effect of N-(bis(2-chlorethyl)-aminomethyl)-amides. 21. Cytostatic agents]. Arch Pharm (Weinheim) (1973) 0.75
Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 2. Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrols. J Med Chem (1984) 0.75
[Cis-dichloro(bis(oligopeptide ester))platinum (II) complexes: studies on the demonstration of their antitumor action with a bacteriological test system]. Arch Pharm (Weinheim) (1984) 0.75
[Pharmacology of potential antidepressants of the N-L-phenylalanyl-beta-phenylalkylamine class]. Arzneimittelforschung (1983) 0.75
[Experimental chemotherapy of mammary neoplasms. A review]. Pharmazie (1976) 0.75
[Synthesis and pharmacological test of N-(3'-methoxy-benzamidomethyl)-D-norephedrine and Analogous Compounds (author's transl)]. Arch Pharm (Weinheim) (1976) 0.75
[The relationship between structure and tuberculostatic effect in the benzylamine group]. Pharmazie (1976) 0.75
[Antineoplastic effect of N,N',N''-trihydroxymethylmelamine and analogous compounds. 23. Cytostatic agents]. Arch Pharm (Weinheim) (1973) 0.75
Anticancer drugs: estrophilic cisplatin derivatives. Cancer Treat Rev (1987) 0.75
Synthesis and evaluation of catechol analogs of diethylstilbestrol on a hormone-dependent human mammary carcinoma implanted in nude mice. J Cancer Res Clin Oncol (1982) 0.75
[14C-labeling of D 16,427, a new positive inotropic agent]. Arch Pharm (Weinheim) (1986) 0.75
Mammary tumor inhibiting properties of the (S,S)-configurated [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complex. Arch Pharm (Weinheim) (1990) 0.75
[The effect of the culture medium on the testing of antimycobacterial compounds]. Arch Pharm (Weinheim) (1989) 0.75
[Antimycobacterial effect of N-alkylbenzylamines]. Pharmazie (1977) 0.75
Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes. J Med Chem (1986) 0.75
Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties. J Med Chem (1985) 0.75
The tumor-inhibiting effect of isomeric dichloro(diphenylethylenediamine)platinum(II) complexes. J Cancer Res Clin Oncol (1984) 0.75